Anti-pro363 antibodies

Details Anti-pro363 antibodies Anti-pro363 antibodies

2007-03-27

2007-03-27

Angell, Jon (Department: 1635)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

C424S133100, C424S134100, C424S135100, C424S141100

Reexamination Certificate

active

09978564

ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

REFERENCES:
patent: 2002/0055139 (2002-05-01), Holtzman et al.
Blast Results A1-A12 (Alignment of DNA45419 and various nucleotide sequences—GenBank Database). Oct. 4, 2001.
Blast Results B1-B7 (Alignment of DNA45419 and various polypeptide sequences—Dayhoff Database). Oct. 3, 2001.
Adams, M.D. et al., “EST20256 Retina IIHomo sapienscDNA 5′ end”,GenBank, Accession No. AA318060, EST. Apr. 19, 1997, Publishe: Nature 377 (6547 Suppl). 3-174 (1995).
Marra, M. et al., “ub12f10.rl Soares Mammary Gland NbMGMus musculuscDNA Clone Image: 1366795 5′ Similar to TR: P78310 P78310 Coxsackie and Adenovirus Receptor Protein: mRNA sequence”.GenBank, Accession No. A1021505, EST. Jun. 16, 1998. Unpublished.
Strausberg, R. ox29e06.xl Soares total fetus Nb2HF8 9wHomo sapienscDNA Clone Image: 1657762 3′, mRNA Sequence.GenBank. Accession No. A1038014. EST Aug. 28, 1998. Unpublished.
Dayhoff, Accession No. P—AAB65293, WO 200073454-A1, Pub Date: Dec. 7, 2000, A. J. Ashkenazi et al.
Dayhoff, Accession No. P—AAB48108, WO 200069885-A2, Pub Date: Nov. 23, 2000, Y. Pan et al.
Dayhoff, Accession No. P—AAB33430, WO 200053758-A2, Pub. Date: Sep. 14, 2000, A. J. Ashkenazi et al.
Dayhoff, Accession No. P—AAB44248, WO 200053756-A2, Pub. Date: Sep. 14, 2000, A. J. Ashkenazi et al.
Dayhoff, Accession No. P—AAY41692, WO 9946281-A2, Sep. 16, 1999, W. I. Wood et al.
Dayhoff, Accession No. AAH09371, Direct Submission, Submitted: Jun. 12, 2001, R. Strausberg.
Dayhoff, Accession No. Direct Submission, Submitted: Aug. 29, 2000, S. Sugano et al.
Dayhoff, Accession No. P—AAB48147, WO 200069885-A2, Pub Date: Nov. 23, 2000, Y. Pan et al.
Dayhoff, Accession No. P—AAB48146, WO 200069885-A2, Pub Date: Nov. 23, 2000, Y. Pan et al.
Dayhoff, Accession No. P—AAB48145, WO 200069885-A2, Pub Date: Nov. 23, 2000, Y. Pan et al.
GenBank, Accession No. P—AAF44262, WO 200073454-A1, Pub Date: Dec. 7, 2000, A. J. Ashkenazi et al.
GenBank, Accession No. P—AAC58595, WO 200053758A2, Pub Date: Sep. 14, 2000, A. J. Ashkenazi et al.
GenBank, Accession No. AK026068, Direct Submission, Submitted: Aug. 29, 2000, S. Sugano et al.
GenBank, Accession No. BC009371, Direct Submission, Submitted: Jun. 12, 2001, R. Strausberg.

Affiliated with

Also associated with

Rating

Anti-pro363 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-pro363 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-pro363 antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3759117